Who owns SAREPTA THERAPEUTICS INC NOTE 1.250 9/1?
- CUSIP Number: 803607ad2
Tip: Access positions for across all investors
Analyze quarterly positions in Sarepta Therapeutics Inc Note 1.250 9/1 with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Sarepta Therapeutics Inc Note 1.250 9/1 stock
Who bought or sold SAREPTA THERAPEUTICS INC NOTE 1.250 9/1 this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Wolverine Asset Management | 76M | $77M | 2% | Dec 2023 |
|
Calamos Advisors | 60M | $60M | 0% | Dec 2023 |
|
Braidwell | 51M | $52M | 15% | Dec 2023 |
|
Highbridge Capital Management | 50M | $51B | 61% | Dec 2023 |
|
Davidson Kempner Capital Management | 45M | $46M | 7% | Dec 2023 |
|
Readystate Asset Management | 43M | $44M | 54% | Dec 2023 |
|
Bank of America Corporation | 42M | $42M | -6% | Dec 2023 |
|
Lazard Asset Management | 40M | $41M | -17% | Dec 2023 |
|
Tenor Capital Management | 39M | $39B | 10% | Dec 2023 |
|
D. E. Shaw & Co | 37M | $37M | 28% | Dec 2023 |
|
Bank Of Montreal | 27M | $28M | -6% | Dec 2023 |
|
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 16M | $16M | -2% | Dec 2023 |
|
Steelhead Partners | 16M | $16B | 100% | Dec 2023 |
|
Context Capital Management | 15M | $15B | 66583% | Dec 2023 |
|
Capstone Investment Advisors | 9.0M | $9.2M | -36% | Dec 2023 |
|
New York State Common Retirement Fund | 8.4M | $8.5M | 153% | Dec 2023 |
|
Weiss Asset Management LP[1 | 6.3M | $6.3M | 100% | Dec 2023 |
|
CNH Partners | 5.6M | $5.7M | 100% | Dec 2023 |
|
SSI Investment Management | 5.4M | $5.5M | -1% | Dec 2023 |
|
Man Group | 5.3M | $5.4M | -21% | Dec 2023 |
|
Balyasny Asset Management | 5.0M | $5.1M | 100% | Dec 2023 |
|
RWC Asset Management | 4.3M | $4.4M | 0% | Dec 2023 |
|
Shenkman Capital Management | 3.5M | $3.6B | -5% | Dec 2023 |
|
Amundi | 3.5M | $3.9M | 0% | Dec 2023 |
|
Wellesley Investment Advisors | 2.8M | $2.8B | 100% | Dec 2023 |
|
Jpmorgan Chase & Co | 2.5M | $2.5M | -34% | Dec 2023 |
|
Palisade Capital Management | 2.1M | $2.1M | 0% | Dec 2023 |
|
Edmond De Rothschild Holding | 1.9M | $1.9M | 0% | Dec 2023 |
|
Bnp Paribas Arbitrage, Snc | 1.8M | $1.8M | 100% | Dec 2023 |
|
Agf Management | 1.7M | $1.7M | 0% | Dec 2023 |
|
Bank of New York Mellon | 900k | $1.1M | 0% | Mar 2024 |
|
Wells Fargo & Company | 875k | $889k | 92% | Dec 2023 |
|
Groupama Asset Managment | 800k | $814k | 100% | Dec 2023 |
|
Zurcher Kantonalbank | 650k | $756k | -13% | Mar 2024 |
|
Barclays | 516k | $524k | 100% | Dec 2023 |
|
Russell Investments | 451k | $459k | -12% | Dec 2023 |
|
Citigroup | 118k | $119k | -48% | Dec 2023 |
|
First Hawaiian Bank | 109k | $127k | 0% | Mar 2024 |
|
Calamos Wealth Management | 55k | $56k | -29% | Dec 2023 |
|
SG Americas Securities | 39k | $3.9M | 0% | Dec 2023 |
|
Aurum Wealth Management Group | 17k | $17k | 100% | Dec 2023 |
|
Candriam Luxembourg S.C.A. | 600.00 | $612k | 100% | Dec 2023 |
|
Who sold out of Sarepta Therapeutics Inc Note 1.250 9/1?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Graham Capital Management | Sep 2023 | 18M | $20M |
Royal Bank of Canada | Sep 2023 | 8.8M | $9.9M |
Lord, Abbett & Co | Sep 2023 | 5.3M | $5.9M |
Whitebox Advisors | Sep 2023 | 5.0M | $5.6M |
683 Capital Management | Sep 2023 | 3.0M | $3.4M |
Aviva | Sep 2023 | 3.0M | $3.4M |
Alberta Investment Management Corporation | Sep 2023 | 2.5M | $2.8M |
Millennium Management | Sep 2023 | 2.0M | $2.2M |
Skaana Management | Sep 2023 | 2.0M | $2.2M |
Nicholas Investments Partners | Sep 2023 | 1.9M | $2.1M |
Nomura Holdings | Sep 2023 | 59k | $7.0M |